LON:SENS

Sensyne Health Competitors

GBX 157.50
0.00 (0.00 %)
(As of 05/11/2021 12:00 AM ET)
Add
Compare
Today's Range
155
159.40
50-Day Range
157.50
176.50
52-Week Range
26.10
190
Volume54,810 shs
Average Volume326,792 shs
Market Capitalization£259.56 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Sensyne Health (LON:SENS) Vs. TEP, XPP, CDM, TM17, EMIS, and NCC

Should you be buying SENS stock or one of its competitors? Companies in the sector of "computer and technology" are considered alternatives and competitors to Sensyne Health, including Telecom Plus (TEP), XP Power (XPP), Codemasters Group (CDM), Team17 Group (TM17), EMIS Group (EMIS), and NCC Group (NCC).

Sensyne Health (LON:SENS) and Telecom Plus (LON:TEP) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.

Valuation and Earnings

This table compares Sensyne Health and Telecom Plus' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sensyne Health£3.98 million65.28N/AGBX (20)-7.88
Telecom Plus£871.94 million1.14N/AGBX 47.1026.62

Sensyne Health is trading at a lower price-to-earnings ratio than Telecom Plus, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent recommendations for Sensyne Health and Telecom Plus, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sensyne Health00203.00
Telecom Plus01102.50

Sensyne Health currently has a consensus target price of GBX 310, suggesting a potential upside of 96.83%. Telecom Plus has a consensus target price of GBX 1,425, suggesting a potential upside of 13.64%. Given Sensyne Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Sensyne Health is more favorable than Telecom Plus.

Profitability

This table compares Sensyne Health and Telecom Plus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sensyne HealthN/AN/AN/A
Telecom PlusN/AN/AN/A

Summary

Sensyne Health beats Telecom Plus on 4 of the 7 factors compared between the two stocks.

XP Power (LON:XPP) and Sensyne Health (LON:SENS) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings for XP Power and Sensyne Health, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
XP Power00303.00
Sensyne Health00203.00

XP Power currently has a consensus price target of GBX 5,498.33, suggesting a potential upside of 13.37%. Sensyne Health has a consensus price target of GBX 310, suggesting a potential upside of 96.83%. Given Sensyne Health's higher probable upside, analysts clearly believe Sensyne Health is more favorable than XP Power.

Profitability

This table compares XP Power and Sensyne Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
XP PowerN/AN/AN/A
Sensyne HealthN/AN/AN/A

Earnings and Valuation

This table compares XP Power and Sensyne Health's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XP Power£233.30 million4.08N/AGBX 160.3030.26
Sensyne Health£3.98 million65.28N/AGBX (20)-7.88

Sensyne Health is trading at a lower price-to-earnings ratio than XP Power, indicating that it is currently the more affordable of the two stocks.

Summary

XP Power beats Sensyne Health on 4 of the 6 factors compared between the two stocks.

Codemasters Group (LON:CDM) and Sensyne Health (LON:SENS) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Profitability

This table compares Codemasters Group and Sensyne Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Codemasters GroupN/AN/AN/A
Sensyne HealthN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for Codemasters Group and Sensyne Health, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Codemasters Group03302.50
Sensyne Health00203.00

Codemasters Group currently has a consensus target price of GBX 446.80, suggesting a potential downside of 25.78%. Sensyne Health has a consensus target price of GBX 310, suggesting a potential upside of 96.83%. Given Sensyne Health's stronger consensus rating and higher possible upside, analysts clearly believe Sensyne Health is more favorable than Codemasters Group.

Valuation and Earnings

This table compares Codemasters Group and Sensyne Health's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Codemasters Group£116.78 million8.06N/AGBX 14.2042.39
Sensyne Health£3.98 million65.28N/AGBX (20)-7.88

Sensyne Health is trading at a lower price-to-earnings ratio than Codemasters Group, indicating that it is currently the more affordable of the two stocks.

Summary

Codemasters Group beats Sensyne Health on 4 of the 7 factors compared between the two stocks.

Team17 Group (LON:TM17) and Sensyne Health (LON:SENS) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation & Earnings

This table compares Team17 Group and Sensyne Health's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Team17 Group£82.97 million10.54N/AGBX 16.8039.58
Sensyne Health£3.98 million65.28N/AGBX (20)-7.88

Sensyne Health is trading at a lower price-to-earnings ratio than Team17 Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Team17 Group and Sensyne Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Team17 GroupN/AN/AN/A
Sensyne HealthN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations for Team17 Group and Sensyne Health, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Team17 Group20502.43
Sensyne Health00203.00

Team17 Group currently has a consensus target price of GBX 778.25, suggesting a potential upside of 17.03%. Sensyne Health has a consensus target price of GBX 310, suggesting a potential upside of 96.83%. Given Sensyne Health's stronger consensus rating and higher possible upside, analysts plainly believe Sensyne Health is more favorable than Team17 Group.

Summary

Team17 Group beats Sensyne Health on 4 of the 7 factors compared between the two stocks.

EMIS Group (LON:EMIS) and Sensyne Health (LON:SENS) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

Earnings and Valuation

This table compares EMIS Group and Sensyne Health's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EMIS Group£159.45 million4.72N/AGBX 47.6025.00
Sensyne Health£3.98 million65.28N/AGBX (20)-7.88

Sensyne Health is trading at a lower price-to-earnings ratio than EMIS Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares EMIS Group and Sensyne Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EMIS GroupN/AN/AN/A
Sensyne HealthN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for EMIS Group and Sensyne Health, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
EMIS Group0000N/A
Sensyne Health00203.00

Sensyne Health has a consensus target price of GBX 310, suggesting a potential upside of 96.83%. Given Sensyne Health's higher possible upside, analysts plainly believe Sensyne Health is more favorable than EMIS Group.

NCC Group (LON:NCC) and Sensyne Health (LON:SENS) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

Profitability

This table compares NCC Group and Sensyne Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NCC GroupN/AN/AN/A
Sensyne HealthN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for NCC Group and Sensyne Health, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
NCC Group02302.60
Sensyne Health00203.00

NCC Group presently has a consensus target price of GBX 236.75, suggesting a potential downside of 8.41%. Sensyne Health has a consensus target price of GBX 310, suggesting a potential upside of 96.83%. Given Sensyne Health's stronger consensus rating and higher possible upside, analysts plainly believe Sensyne Health is more favorable than NCC Group.

Earnings and Valuation

This table compares NCC Group and Sensyne Health's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NCC Group£266.60 million2.72N/AGBX 4.5057.44
Sensyne Health£3.98 million65.28N/AGBX (20)-7.88

Sensyne Health is trading at a lower price-to-earnings ratio than NCC Group, indicating that it is currently the more affordable of the two stocks.

Summary

NCC Group beats Sensyne Health on 4 of the 7 factors compared between the two stocks.


Sensyne Health Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Telecom Plus logo
TEP
Telecom Plus
1.6$1,254.00flat£992.93 million£871.94 million26.62News Coverage
XP Power logo
XPP
XP Power
1.6$4,850.00flat£952.64 million£233.30 million30.26
Codemasters Group logo
CDM
Codemasters Group
1.2$602.00flat£917.86 million£116.78 million42.39
Team17 Group logo
TM17
Team17 Group
1.3$665.00flat£874.30 million£82.97 million39.58High Trading Volume
EMIS Group logo
EMIS
EMIS Group
1.1$1,190.00flat£753.40 million£159.45 million25.00
NCC Group logo
NCC
NCC Group
1.4$258.50flat£726.33 million£266.60 million57.44
First Derivatives logo
FDP
First Derivatives
1.1$2,600.00flat£720.64 million£240.72 million50.29Upcoming Earnings
Craneware logo
CRW
Craneware
1.1$2,650.00flat£710.92 million£73.64 million57.73News Coverage
Ideagen logo
IDEA
Ideagen
1.0$278.00flat£701.39 million£58.42 million1,390.00News Coverage
discoverIE Group logo
DSCV
discoverIE Group
1.1$741.00flat£662.87 million£452.30 million55.71Gap Down
KAPE
Kape Technologies
0.5$295.00flat£657.66 million£122.21 million28.37
NASA
Nasstar
0.3$12.75flat£641.31 million£25.97 million-56.25Gap Down
The Vitec Group logo
VTC
The Vitec Group
0.9$1,370.00flat£631.75 million£290.50 million-118.10Insider Selling
Gap Up
Sumo Group logo
SUMO
Sumo Group
1.0$353.42flat£605.38 million£68.95 million353.42
SDL plc (SDL.L) logo
SDL
SDL plc (SDL.L)
1.4$660.00flat£593.51 million£374.50 million28.09High Trading Volume
Strix Group logo
KETL
Strix Group
1.6$275.00flat£578.19 million£95.31 million23.50
dotdigital Group logo
DOTD
dotdigital Group
1.0$192.40flat£573.30 million£52.56 million53.44Gap Up
GoCo Group plc (GOCO.L) logo
GOCO
GoCo Group plc (GOCO.L)
1.1$131.60flat£555.09 million£159.20 million48.74
Luceco logo
LUCE
Luceco
1.4$319.00flat£521.80 million£176.20 million18.02
AB Dynamics logo
ABDP
AB Dynamics
1.0$2,300.00flat£520.31 million£54.12 million179.69
Boku logo
BOKU
Boku
0.9$174.00flat£511.40 million£56.40 million-35.51
Volex logo
VLX
Volex
1.6$323.00flat£507.28 million£398.11 million32.30Gap Up
IMO
IMImobile
0.6$594.00flat£489.58 million£164.04 million123.75News Coverage
TFW
FW Thorpe
0.8$378.00flat£440.97 million£112.30 million33.16
STP
Stenprop
1.3$153.25flat£438.15 million£45.05 million16.66
Midwich Group logo
MIDW
Midwich Group
1.4$492.50flat£436.38 million£711.75 million-114.53Dividend Cut
News Coverage
IQE logo
IQE
IQE
1.3$53.80flat£431.10 million£178.02 million-134.50
TT Electronics logo
TTG
TT Electronics
1.1$244.00flat£426.59 million£431.80 million305.00
Seeing Machines logo
SEE
Seeing Machines
0.4$10.90flat£414.81 million£42.32 million-18.17
Alfa Financial Software logo
ALFA
Alfa Financial Software
1.4$136.00flat£408 million£78.87 million20.00News Coverage
Gap Up
PPS
Proton Motor Power Systems
0.9$51.00flat£394.93 million£1.60 million-4.51Gap Down
BATM Advanced Communications logo
BVC
BATM Advanced Communications
0.5$89.20flat£392.87 million£183.57 million55.75Gap Up
APTD
Aptitude Software Group
1.4$654.00flat£375.87 million£57.27 million53.17
Judges Scientific logo
JDG
Judges Scientific
1.4$5,800.00flat£365.81 million£79.87 million45.07Insider Buying
News Coverage
iomart Group logo
IOM
iomart Group
1.0$267.50flat£292.99 million£113.76 million26.23Gap Up
Gooch & Housego logo
GHH
Gooch & Housego
1.2$1,165.00flat£291.73 million£122.10 million77.67
IDOX logo
IDOX
IDOX
0.6$61.80flat£275.14 million£68.02 million206.00Gap Up
Ilika logo
IKA
Ilika
1.2$195.00flat£271.12 million£2.63 million-72.22News Coverage
accesso Technology Group logo
ACSO
accesso Technology Group
1.6$650.00flat£267.90 million£56.09 million-10.73
Telit Communications logo
TCM
Telit Communications
0.7$197.40flat£265.29 million£343.62 million59.82Gap Down
Tracsis logo
TRCS
Tracsis
0.6$860.00flat£252.08 million£43.87 million150.88
WANdisco logo
WAND
WANdisco
0.6$419.00flat£249.30 million£10.53 million-8.62
TPX
The Panoply
0.7$300.00flat£242.22 million£39.28 million-31.91Insider Buying
Quartix logo
QTX
Quartix
0.7$485.00flat£234.26 million£25.84 million49.49Gap Up
Microgen logo
MCGN
Microgen
1.0$367.50flat£228.50 million£70.29 million17.09
Redcentric logo
RCN
Redcentric
1.2$143.00flat£223.27 million£90.57 million-23.83
CentralNic Group logo
CNIC
CentralNic Group
0.6$83.30flat£194.70 million£241.21 million-26.87Gap Down
Blancco Technology Group logo
BLTG
Blancco Technology Group
1.5$255.00flat£192.73 million£33.41 million196.15
RM logo
RM
RM
1.6$228.00flat£191.24 million£189.00 million22.57News Coverage
Cerillion logo
CER
Cerillion
0.9$622.00flat£183.57 million£20.81 million70.68
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.